Pharmaceutical companies, in principle, agree to pay hundreds of millions of dollars.
Under the interim settlement, Mylan Inc., now part of Viatris, will deliver up to $335 million to participating states over nine years, California Attorney General Rob Bonta announced Monday.
Since 2005, Mylan has manufactured and sold a variety of opioids, including fentanyl patches, oxycodone, hydrocodone, and buprenorphine products.
“The Attorney General argues that Mylan has seen it as unpopular to abuse its products despite knowing for years that many of its opioid products, particularly fentanyl patches, are actually more vulnerable to abuse,” the California Department of Justice said in a news release Monday.
Mylan Laboratories Inc. headquarters is depicted in Cannonsburg, Pennsylvania on Tuesday, November 1, 2005 (Jason Corn/Bloomberg via Getty Images)
Authorities alleged that Mylan promoted the opioid crisis by selling directly to doctors, which led to the opioid’s shift into the illegal drug market.
“The businesses and individuals who fueled the opioid crisis must be accountable. With today’s announcement, the California Department of Justice continues to deliver results,” Bonta said.
The interim settlement was negotiated by the California Attorney General, Illinois, Massachusetts, New York, North Carolina, Oregon, Tennessee, Utah and Virginia.
Source link
